Home » Chelsea Therapeutics Announces FDA Advisory Committee Meeting Date for Review of Northera NDA
Chelsea Therapeutics Announces FDA Advisory Committee Meeting Date for Review of Northera NDA
Chelsea Therapeutics International announced that the FDA has scheduled a meeting of the Cardiovascular and Renal Drugs Advisory Committee on Feb. 23 to review the NDA for Northera (droxidopa).
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
07May
-
14May
-
30May